Modi inducts indigenous warship INS Kolkata

August 16, 2014

Mumbai, August 16: Terming military might as the biggest deterrent to war, Prime Minister Narendra Modi today said the defence forces will be modernised to ensure that "nobody casts an evil eye" on the nation.ins kolkata

"Fighting a war and winning it has now become less difficult these days. But a modern military, armed with state of the arm weaponry alone is a guarantee against war. When we are capable, no one can dare challenge us," Modi said addressing a gathering after dedicating the largest indigenously built warship INS Kolkata to the nation.

"When people have a sense of our military capability, nobody will ever dare to cast an evil eye on our nation," he said.

Stressing the importance of maritime security in fast expanding global trade and commerce, the Prime Minister said India, with its vast coastline, was playing a major role in it.

"In the coming days, INS Kolkata will inspire confidence to those involved in maritime trade," he said.

Describing the building of the destroyer ship as a big achievement by India's technicians, engineers and defence experts, Modi said the government was committed to modernising the defence forces so "our jawans don't feel they are lagging behind in defending our nation.

"When I dedicate INS Kolkata to the nation, I am confident it will boost our military prowess and give confidence to our soldiers." Defence Minister Arun Jaitley and Chief of the Naval Staff Admiral RK Dhowan were present at the ceremony held at the Naval dockyard.

The warship, constructed by the Mazagon Dockyards Limited, has been designed by Navy's design bureau. The 6,800 tonne warship is a technology demonstrator and will showcase a giant leap in shipbuilding technology in the country.

The Prime Minister had dedicated India's largest warship INS Vikramaditya to the nation in June in his first outing after taking charge. Modi said that the government has taken important decisions in its budget and has given priority to "defence upgrade".

Referring to the decision of allowing 49 per cent FDI in defence, Modi said, "We have to import (military hardware)... Because of this one decision, India can become self-reliant in this sector. Our youth will become innovative and a day will come when India will export in this sector."

INS Kolkata will be a part of the Kolkata Class destroyers of the Indian Navy which will include follow-on ships by the name of INS Kochi and INS Chennai respectively. The keel of the warship was laid down in September 2003 and the ship was launched in 2006. Its original commissioning was planned in 2010 but there were delays.

The ship had also suffered a mishap during the trial phase when a Navy officer lost his life during an incident in the fire-fighting equipment of the vessel.

The Prime Minister, on his day long visit to Maharashtra, will also lay the foundation for a multi-crore SEZ and port connectivity project in Navi Mumbai, dedicate a Powergrid's transmission line and launch multiple road and highway projects in Solapur.

Regarded as the most potent warship to have been constructed in India yet, INS Kolkata measures 164 meters in length, approximately 18 meters in width and has a full load displacement of 7400 tonnes.

The ship has a Combined Gas and Gas (COGAG) propulsion system, consisting of four powerful reversible gas turbines and can attain speeds in excess of 30 knots, a defence release said.

The warship's electric power is provided by four gas turbine generators and one diesel alternator, which together produce 4.5 Mega-Watts of electrical power, enough to light up a small town. It has a complement of 30 officers and 300 sailors.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 24,2020

Thiruvananthapuram, Jun 24: Kerala on Tuesday was among those honoured for tackling the Covid-19 pandemic when the United Nations celebrated the Public Service Day.

The function, held on a virtual platform, saw the participation of UN Secretary General Antonio Guterres and other top UN dignitaries who applauded all the leaders which included state Health Minister K.K. Shailaja for effectively tackling Covid-19.

Speaking on the occasion, Shailaja noted that the experiences of tackling Nipah virus and the two floods - 2018 and 2019 - where the health sector played a crucial role, all helped in tackling Covid-19 timely.

"Right from the time when Covid cases got reported in Wuhan, Kerala got into the track of the WHO and followed every standard operating protocols and international norms and hence, we have been able to keep the contact spread rate to below 12.5 per cent and the mortality rate to 0.6 per cent," she said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 9,2020

Feb 9: The Electronic Voting Machines (EVMs) used in Delhi Assembly polls are kept under tight security, in the 'Strong Room' located at Atal Adarsh Bengali Balika Vidyalaya in Gol Market.

Voting for Delhi Assembly elections took place on Saturday with voters turnout well short of the 2015 election mark.

Counting of the votes will be on February 11.

Earlier, Deputy Election Commissioner Sudip Jain had said the Delhi elections took place peacefully and smoothly.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.